Apeptico

Contact
apeptico.com
+43 664 1432919

Apeptico Forschung und Entwicklung GmbH

Mariahilferstraße 136
1150 Wien
Austria
+43 664 1432919
apeptico.com
Contact
Profile Products News
Contact

About Apeptico

AAPEPTICO, a privately-held biotechnology company located in Austria, develops peptide-based products targeting chronic and life-threatening diseases using its PEPBASE™ discovery technology.

Read more about Apeptico
Facts about Apeptico
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of Apeptico

Product portfolio

Show all

News about Apeptico

Apeptico

01-Nov-2011 | research and development

APEPTICO Announces Successful Completion of Phase I Trial with AP301 in Oedematous Respiratory Failure

APEPTICO GmbH announced completion of a Phase I clinical trial for its pulmonary sodium ion channel activator AP301. The orally inhaled drug candidate was ...

Read news
Apeptico

13-Apr-2011 | research and development

APEPTICO Initiates Phase I Trial with AP301 in Pulmonary Oedema

APEPTICO, a privately-held biotechnology company developing peptide drugs,  announced the initiation of a Phase I clinical trial with its lead product ...

Read news
Show more news about Apeptico

Here you will find Apeptico Forschung und Entwicklung GmbH